Net (loss) income per share - Antidilutive (Details) - shares |
9 Months Ended | |
|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Net income (loss) per share | ||
| Total shares excluded from calculation (in shares) | 956,720 | 3,337,289 |
| Stock options | ||
| Net income (loss) per share | ||
| Total shares excluded from calculation (in shares) | 875,727 | 3,246,389 |
| Unvested restricted stock units | ||
| Net income (loss) per share | ||
| Total shares excluded from calculation (in shares) | 5,100 | 90,900 |
| Unvested performance based restricted stock units | ||
| Net income (loss) per share | ||
| Total shares excluded from calculation (in shares) | 75,893 | |